Loading…
Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview
Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM...
Saved in:
Published in: | Biotechnology and applied biochemistry 2020-11, Vol.67 (6), p.920-928 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73 |
---|---|
cites | cdi_FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73 |
container_end_page | 928 |
container_issue | 6 |
container_start_page | 920 |
container_title | Biotechnology and applied biochemistry |
container_volume | 67 |
creator | Chung, Ill‐Min Rajakumar, Govindasamy Subramanian, Umadevi Venkidasamy, Baskar Khanna, Venkatesan Gopiesh Thiruvengadam, Muthu |
description | Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β‐cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review.
Treatment strategies of type 2 diabetes. |
doi_str_mv | 10.1002/bab.1853 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2315526035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2477153112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73</originalsourceid><addsrcrecordid>eNp1kV1rFDEUhoModlsFf4EEvPFmar5mk3i3LVoLhd7U63CSOWNTZiZrktmy_97ZtioUenXg5eHh5byEfODslDMmvnjwp9y08hVZcaVZY7RSr8mKGdM2quXyiByXcscYM9qIt-RIci3X3KoVyZdTib9ua6FpovUWaZhzxqnSUqHOhcLUUeh2MAUcD3HqaRfBY8VCRxyGeIDqfotUPLA1UdhhrjSkcTvEADWmqXylm4mmJd9FvH9H3vQwFHz_dE_Iz-_fbs5_NFfXF5fnm6smSGVl01nU0ggVwPp1p8F7NAqMtaEHaSxo3QN03Ji1Ytay3vRGdhKNt5x7EbQ8IZ8fvducfs9YqhtjCUtnmDDNxQnJ21asmWwX9NMz9C7NeVraOaG05q3kXPwXhpxKydi7bY4j5L3jzB12cMsO7rDDgn58Es5-xO4f-PfxC9A8AvdxwP2LIne2OXsQ_gGlCZFz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2477153112</pqid></control><display><type>article</type><title>Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Chung, Ill‐Min ; Rajakumar, Govindasamy ; Subramanian, Umadevi ; Venkidasamy, Baskar ; Khanna, Venkatesan Gopiesh ; Thiruvengadam, Muthu</creator><creatorcontrib>Chung, Ill‐Min ; Rajakumar, Govindasamy ; Subramanian, Umadevi ; Venkidasamy, Baskar ; Khanna, Venkatesan Gopiesh ; Thiruvengadam, Muthu</creatorcontrib><description>Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β‐cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review.
Treatment strategies of type 2 diabetes.</description><identifier>ISSN: 0885-4513</identifier><identifier>EISSN: 1470-8744</identifier><identifier>DOI: 10.1002/bab.1853</identifier><identifier>PMID: 31736194</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aging ; antiglycemic agents ; Beta cells ; completions ; Complications ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; diabetes mellitus type 2 ; Insulin ; Insulin resistance ; Metabolic disorders ; Modernization ; Pancreas ; Pathophysiology ; Physical activity ; treatment strategies</subject><ispartof>Biotechnology and applied biochemistry, 2020-11, Vol.67 (6), p.920-928</ispartof><rights>2019 International Union of Biochemistry and Molecular Biology, Inc.</rights><rights>2020 International Union of Biochemistry and Molecular Biology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73</citedby><cites>FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73</cites><orcidid>0000-0003-0986-5484</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31736194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chung, Ill‐Min</creatorcontrib><creatorcontrib>Rajakumar, Govindasamy</creatorcontrib><creatorcontrib>Subramanian, Umadevi</creatorcontrib><creatorcontrib>Venkidasamy, Baskar</creatorcontrib><creatorcontrib>Khanna, Venkatesan Gopiesh</creatorcontrib><creatorcontrib>Thiruvengadam, Muthu</creatorcontrib><title>Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview</title><title>Biotechnology and applied biochemistry</title><addtitle>Biotechnol Appl Biochem</addtitle><description>Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β‐cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review.
Treatment strategies of type 2 diabetes.</description><subject>Aging</subject><subject>antiglycemic agents</subject><subject>Beta cells</subject><subject>completions</subject><subject>Complications</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>diabetes mellitus type 2</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Metabolic disorders</subject><subject>Modernization</subject><subject>Pancreas</subject><subject>Pathophysiology</subject><subject>Physical activity</subject><subject>treatment strategies</subject><issn>0885-4513</issn><issn>1470-8744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kV1rFDEUhoModlsFf4EEvPFmar5mk3i3LVoLhd7U63CSOWNTZiZrktmy_97ZtioUenXg5eHh5byEfODslDMmvnjwp9y08hVZcaVZY7RSr8mKGdM2quXyiByXcscYM9qIt-RIci3X3KoVyZdTib9ua6FpovUWaZhzxqnSUqHOhcLUUeh2MAUcD3HqaRfBY8VCRxyGeIDqfotUPLA1UdhhrjSkcTvEADWmqXylm4mmJd9FvH9H3vQwFHz_dE_Iz-_fbs5_NFfXF5fnm6smSGVl01nU0ggVwPp1p8F7NAqMtaEHaSxo3QN03Ji1Ytay3vRGdhKNt5x7EbQ8IZ8fvducfs9YqhtjCUtnmDDNxQnJ21asmWwX9NMz9C7NeVraOaG05q3kXPwXhpxKydi7bY4j5L3jzB12cMsO7rDDgn58Es5-xO4f-PfxC9A8AvdxwP2LIne2OXsQ_gGlCZFz</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Chung, Ill‐Min</creator><creator>Rajakumar, Govindasamy</creator><creator>Subramanian, Umadevi</creator><creator>Venkidasamy, Baskar</creator><creator>Khanna, Venkatesan Gopiesh</creator><creator>Thiruvengadam, Muthu</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TB</scope><scope>7TK</scope><scope>7U5</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>L7M</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0986-5484</orcidid></search><sort><creationdate>202011</creationdate><title>Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview</title><author>Chung, Ill‐Min ; Rajakumar, Govindasamy ; Subramanian, Umadevi ; Venkidasamy, Baskar ; Khanna, Venkatesan Gopiesh ; Thiruvengadam, Muthu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aging</topic><topic>antiglycemic agents</topic><topic>Beta cells</topic><topic>completions</topic><topic>Complications</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>diabetes mellitus type 2</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Metabolic disorders</topic><topic>Modernization</topic><topic>Pancreas</topic><topic>Pathophysiology</topic><topic>Physical activity</topic><topic>treatment strategies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chung, Ill‐Min</creatorcontrib><creatorcontrib>Rajakumar, Govindasamy</creatorcontrib><creatorcontrib>Subramanian, Umadevi</creatorcontrib><creatorcontrib>Venkidasamy, Baskar</creatorcontrib><creatorcontrib>Khanna, Venkatesan Gopiesh</creatorcontrib><creatorcontrib>Thiruvengadam, Muthu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology and applied biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chung, Ill‐Min</au><au>Rajakumar, Govindasamy</au><au>Subramanian, Umadevi</au><au>Venkidasamy, Baskar</au><au>Khanna, Venkatesan Gopiesh</au><au>Thiruvengadam, Muthu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview</atitle><jtitle>Biotechnology and applied biochemistry</jtitle><addtitle>Biotechnol Appl Biochem</addtitle><date>2020-11</date><risdate>2020</risdate><volume>67</volume><issue>6</issue><spage>920</spage><epage>928</epage><pages>920-928</pages><issn>0885-4513</issn><eissn>1470-8744</eissn><abstract>Type 2 diabetes mellitus (T2DM) is an endocrine metabolic disorder, occurring worldwide due to aging, advancement in lifestyle by modernization. T2DM is characterized by higher levels of glucose in the blood due to unresponsive secretion of pancreatic insulin and insulin activity or altogether. T2DM is regarded as a powerful genetic susceptible disease that leads to high risk with insulin resistance and β‐cell dysfunction. To manage and overcome type 2 diabetes, physical activity, diet strategies, and other therapeutic medications along with usage of antiglycemic agents are developed and attempted appropriately. In the present review, attention has been focused on the understanding of T2DM outcomes, complications with possible management strategies, and pathophysiology of T2DM. Further, a detailed note on antiglycemic agents in use and other possible drugs of choice was discussed in the light of current preventive strategies are presented in this review.
Treatment strategies of type 2 diabetes.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31736194</pmid><doi>10.1002/bab.1853</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0986-5484</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-4513 |
ispartof | Biotechnology and applied biochemistry, 2020-11, Vol.67 (6), p.920-928 |
issn | 0885-4513 1470-8744 |
language | eng |
recordid | cdi_proquest_miscellaneous_2315526035 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Aging antiglycemic agents Beta cells completions Complications Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) diabetes mellitus type 2 Insulin Insulin resistance Metabolic disorders Modernization Pancreas Pathophysiology Physical activity treatment strategies |
title | Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T11%3A54%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insights%20on%20the%20current%20status%20and%20advancement%20of%20diabetes%20mellitus%20type%202%20and%20to%20avert%20complications:%20An%20overview&rft.jtitle=Biotechnology%20and%20applied%20biochemistry&rft.au=Chung,%20Ill%E2%80%90Min&rft.date=2020-11&rft.volume=67&rft.issue=6&rft.spage=920&rft.epage=928&rft.pages=920-928&rft.issn=0885-4513&rft.eissn=1470-8744&rft_id=info:doi/10.1002/bab.1853&rft_dat=%3Cproquest_cross%3E2477153112%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3493-d9e73824ca9b6d7abbe84a899cfa389a77faad188640990f8f83d3e8b911b2c73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2477153112&rft_id=info:pmid/31736194&rfr_iscdi=true |